These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17638204)

  • 1. Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy.
    Franceschi S; Jaffe H
    Clin Infect Dis; 2007 Aug; 45(4):510-3. PubMed ID: 17638204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus-related tumors in HIV.
    Palefsky J
    Curr Opin Oncol; 2006 Sep; 18(5):463-8. PubMed ID: 16894294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues in cervical cancer incidence and treatment in HIV.
    Einstein MH; Phaëton R
    Curr Opin Oncol; 2010 Sep; 22(5):449-55. PubMed ID: 20613518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High recurrence rate of cervical dysplasia and persistence of HPV infection in HIV-1-infected women.
    Gingelmaier A; Grubert T; Kaestner R; Mylonas I; Weissenbacher T; Bergauer F; Barthell L; Friese K
    Anticancer Res; 2007; 27(4A):1795-8. PubMed ID: 17649775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of screening guidelines for non-AIDS-defining malignancies: evolving issues in the era of highly active antiretroviral therapy.
    Tyerman Z; Aboulafia DM
    AIDS Rev; 2012; 14(1):3-16. PubMed ID: 22297500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
    Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
    J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women.
    Denny L; Boa R; Williamson AL; Allan B; Hardie D; Stan R; Myer L
    Obstet Gynecol; 2008 Jun; 111(6):1380-7. PubMed ID: 18515522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with hepatitis B and hepatitis C virus infection screening among HIV-1 infected patients in a resource-limited setting.
    Sungkanuparph S; Wongprasit P; Manosuthi W; Atamasirikul K
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):863-6. PubMed ID: 19058581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review.
    Louie KS; de Sanjose S; Mayaud P
    Trop Med Int Health; 2009 Oct; 14(10):1287-302. PubMed ID: 19772550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening in immunocompromised women.
    Nguyen ML; Flowers L
    Obstet Gynecol Clin North Am; 2013 Jun; 40(2):339-57. PubMed ID: 23732035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus testing for primary cervical cancer screening.
    Grce M; Davies P
    Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
    Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
    Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA
    Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and prevention: cervical cancer.
    Weinstein LC; Buchanan EM; Hillson C; Chambers CV
    Prim Care; 2009 Sep; 36(3):559-74. PubMed ID: 19616155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal biochemical serum screening for Down syndrome in pregnancy with human immunodeficiency virus infection.
    Le Meaux JP; Tsatsaris V; Schmitz T; Fulla Y; Launay O; Goffinet F; Azria E
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):223-30. PubMed ID: 18669715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.